Literature DB >> 13269033

Hydrodextran in the treatment of hemorrhagic shock: with plasma volume, blood volume, protein and excretion studies.

J H HARRISON, W F DURDEN, A S KELLUM.   

Abstract

Entities:  

Keywords:  BLOOD PROTEINS; BLOOD VOLUME; DEXTRAN/therapeutic use; PLASMA/effect of drugs on; SHOCK/therapy

Mesh:

Substances:

Year:  1955        PMID: 13269033      PMCID: PMC1465022          DOI: 10.1097/00000658-195511000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

1.  CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER.

Authors:  J G Gibson; W A Evans
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

2.  Studies on Traumatic Shock: I. Blood Volume Changes in Traumatic Shock.

Authors:  E I Evans; M J Hoover; G W James; T Alm
Journal:  Ann Surg       Date:  1944-01       Impact factor: 12.969

3.  Dextran as a plasma substitute with plasma volume and excretion studies on control patients.

Authors:  J H HARRISON
Journal:  Ann Surg       Date:  1954-02       Impact factor: 12.969

4.  Metabolism of plasma substitute. I. Dextran (Macrodex).

Authors:  I GRAY; P K SIITERI; E J PULASKI
Journal:  Proc Soc Exp Biol Med       Date:  1951-08

5.  Tissue changes following the use of plasma substitutes.

Authors:  F W HARTMAN
Journal:  AMA Arch Surg       Date:  1951-12

6.  Present status of plasma volume expanders in the treatment of shock; clinical laboratory studies.

Authors:  W L BLOOM
Journal:  AMA Arch Surg       Date:  1951-12

7.  Determination of dextran in blood and urine.

Authors:  W L BLOOM; M L WILLCOX
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

8.  BLOOD VOLUME IN CLINICAL SHOCK. I. MIXING TIME AND DISAPPEARANCE RATE OF T-1824 IN NORMAL SUBJECTS AND IN PATIENTS IN SHOCK; DETERMINATION OF PLASMA VOLUME IN MAN FROM 10-MINUTE SAMPLE.

Authors:  R P Noble; M I Gregersen; P M Porter; A Buckman
Journal:  J Clin Invest       Date:  1946-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.